HS
INDV icon

HighVista Strategies’s Indivior Pharmaceuticals INDV Stock Holding History

HighVista Strategies’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-142,634
Closed -$1.83M – 157
2024
Q4 		$1.83M Hold
142,634
– – 0.68% 48
2024
Q3 		$1.4M Sell
142,634
-36,202
-20% -$424K 0.48% 87
2024
Q2 		$2.8M Hold
178,836
– – 1.02% 25
2024
Q1 		$3.82M Buy
178,836
+13,995
+8% +$263K 1.36% 18
2023
Q4 		$2.49M Buy
164,841
+34,841
+27% +$619K 0.9% 35
2023
Q3 		$2.82M Hold
130,000
– – 1.31% 20
2023
Q2 		$3.09M Buy
+130,000
New +$2.98M 1.42% 17

Other funds holding INDV

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HighVista Strategies's INDV Position: Q1 2025 in Review

HighVista Strategies sold out of Indivior Pharmaceuticals (INDV) in Q1 2025, closing a stake of 142,634 shares — an estimated $1.83M sold.

HighVista Strategies first reported a position in INDV in Q2 2023 and held it in 7 quarters. The position peaked at $3.82M in Q1 2024. 116 funds tracked by Wall St. Rank hold INDV as of Q1 2025.

  • HighVista Strategies reported no remaining Indivior Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • HighVista Strategies sold 142,634 Indivior Pharmaceuticals shares in Q1 2025, an estimated $1.83M.
  • HighVista Strategies first reported a position in Indivior Pharmaceuticals in Q2 2023 and held it in 7 quarters.
  • HighVista Strategies's Indivior Pharmaceuticals position peaked at $3.82M in Q1 2024.
  • 116 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2025.

Based on HighVista Strategies's 13F filing for Q1 2025, filed 15 May 2025.